TIVC Stock Price, Tivic Health Systems, . Quote, Chart

Market Summary

USD0.47-0.02

Market Closed

-4.08%

TIVC Stock Price

View Fullscreen

TIVC RSI Chart

TIVC Valuation

Market Cap

2.9M

Price/Earnings (Trailing)

-0.38

Price/Sales (Trailing)

2.56

EV/EBITDA

-0.15

Price/Free Cashflow

-0.37

TIVC Price/Sales (Trailing)

TIVC Profitability

Operating Margin

30.07%

EBT Margin

-726.98%

Return on Equity

-353.44%

Return on Assets

-231.57%

Free Cashflow Yield

-272.82%

TIVC Fundamentals

TIVC Revenue

Revenue (TTM)

1.1M

Rev. Growth (Yr)

-11.17%

Rev. Growth (Qtr)

-6.44%

TIVC Earnings

Earnings (TTM)

-7.6M

Earnings Growth (Yr)

30.01%

Earnings Growth (Qtr)

33.99%

Breaking Down TIVC Revenue

Last 7 days

-6%

Last 30 days

-58.0%

Last 90 days

-62.1%

Trailing 12 Months

-96.4%

How does TIVC drawdown profile look like?

TIVC Financial Health

Current Ratio

2.85

TIVC Investor Care

Shares Dilution (1Y)

1983.58%

Diluted EPS (TTM)

-4.85

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1M	0	0	0
2023	1.8M	1.4M	1.2M	1.2M
2022	1.4M	1.6M	1.7M	1.8M
2021	959.3K	1.1M	1.2M	1.3M
2020	0	0	0	860.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Tivic Health Systems, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 12, 2024	bambach kimberly ann	acquired	-	-	7,500	interim cfo
May 16, 2022	drexler karen	sold	-	-	-15,111	-
Nov 12, 2021	ernst jennifer	acquired	-	-	28,377	chief executive officer

Which funds bought or sold TIVC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	sold off	-100	-90.00	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	161	3,452	7,695	-%
May 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	added	15.24	-4,647	15,967	-%
May 13, 2024	UBS Group AG	sold off	-100	-391	-	-%
May 10, 2024	VANGUARD GROUP INC	unchanged	-	-26,390	59,976	-%
May 10, 2024	OSAIC HOLDINGS, INC.	unchanged	-	-80.00	182	-%
May 10, 2024	WELLS FARGO & COMPANY/MN	unchanged	-	-6.00	14.00	-%
May 01, 2024	CONCOURSE FINANCIAL GROUP SECURITIES, INC.	sold off	-	-	-	-%
Aug 14, 2023	One68 Global Capital, LLC	unchanged	-	-853	2,023	0.01%

Are Funds Buying or Selling TIVC?

Are funds buying TIVC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TIVC

No. of Funds

Unveiling Tivic Health Systems, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
May 15, 2024	intracoastal capital, llc	4.99%	324,767	SC 13G
Feb 09, 2024	l1 capital global opportunities master fund, ltd.	0%	0	SC 13G/A
Feb 01, 2024	bigger capital, llc	-	0	SC 13G/A
Jul 24, 2023	l1 capital global opportunities master fund, ltd.	8.8%	1e+07	SC 13G/A
Jul 17, 2023	l1 capital global opportunities master fund, ltd.	9.6%	6e+06	SC 13G
Feb 21, 2023	bigger capital fund l p	3.7%	1,102,988	SC 13G

Recent SEC filings of Tivic Health Systems, Inc.

View All Filings

Date Filed	Form Type	Document
May 15, 2024	SC 13G	Major Ownership Report
May 15, 2024	8-K	Current Report
May 15, 2024	10-Q	Quarterly Report
May 13, 2024	8-K	Current Report
May 13, 2024	424B4	Prospectus Filed
May 09, 2024	EFFECT	EFFECT
May 08, 2024	S-1/A	Initial Public Offering
May 08, 2024	8-K	Current Report
Apr 29, 2024	S-1/A	Initial Public Offering
Mar 29, 2024	S-1	Initial Public Offering

Peers (Alternatives to Tivic Health Systems, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Tivic Health Systems, Inc. News

Latest updates

Tivic Health Systems, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Revenue	-6.4%	334,000	357,000	282,000	161,000	376,000	407,500	477,000	528,000	428,000	408,500	389,000	277,000	268,000	323,000	-
Cost Of Revenue	-52.6%	167,000	352,000	174,000	100,000	263,000	365,500	414,000	403,000	358,000	-	390,500	303,000	301,000	301,000	-
Gross Profit	3240.0%	167,000	5,000	108,000	61,000	113,000	42,000	63,000	125,000	70,000	-	-1,500	-26,000	-33,000	22,000	-
Operating Expenses	-26.7%	1,648,000	2,249,000	1,868,000	2,186,000	2,229,000	2,297,500	2,647,000	3,143,000	2,311,000	-	2,290,500	1,203,000	1,022,000	1,079,000	-
S&GA Expenses	-31.3%	505,000	735,000	480,000	452,000	458,000	498,500	487,000	1,125,000	684,000	-	692,000	450,000	345,000	300,000	-
R&D Expenses	-28.9%	256,000	360,000	337,000	468,000	490,000	434,000	399,000	497,000	401,000	-	313,000	175,000	192,000	198,000	-
EBITDA Margin	-3.7%	-7.26	-7.00	-8.22	-7.09	-5.64	-5.48	-5.30	-6.41	-6.77	-7.14	-7.81	-2.77	-3.03	-3.34	-3.73
Interest Expenses	-	-	-	-	-	-	500	1,000	-	1,000	-	-652,000	-1,171,000	223,000	274,000	-
Earnings Before Taxes	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,356,000	-
EBT Margin	-3.7%	-7.27	-7.01	-8.23	-7.10	-5.64	-5.49	-4.93	-5.28	-5.70	-6.18	-6.76	-3.14	-3.44	-3.79	-4.23
Net Income	34.0%	-1,481,000	-2,243,500	-1,760,000	-2,125,000	-2,116,000	-2,275,000	-2,584,000	-3,018,000	-2,240,000	-	-3,724,000	-2,320,000	-1,094,000	-1,356,000	-
Net Income Margin	4.3%	-6.71	-7.01	-6.75	-6.40	-5.59	-5.50	-4.93	-5.29	-5.70	-6.18	-6.76	-3.14	-3.44	-3.79	-4.23
Free Cashflow	6.1%	-1,700,000	-1,811,000	-1,834,000	-2,490,000	-2,494,000	-2,219,000	-2,805,000	-1,732,000	-2,174,000	-	-	-	-	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet											(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2020Q4
Assets	-36.3%	3,286	5,157	7,007	4,596	7,101	5,875	8,208	11,026	12,694	15,036	1,531
Current Assets	-39.2%	2,827	4,652	6,455	4,000	6,482	5,306	7,594	10,372	11,998	14,289	1,497
Cash Equivalents	-50.9%	1,668	3,400	5,200	2,659	5,200	3,517	6,328	9,049	10,801	12,975	1,044
Inventory	2.4%	774	756	928	988	943	863	761	833	447	429	241
Net PPE	-0.8%	121	122	124	124	104	12.00	15.00	13.00	16.00	11.00	19.00
Liabilities	-28.2%	1,133	1,577	1,242	1,435	1,896	2,245	2,436	2,839	1,601	1,764	2,708
Current Liabilities	-29.2%	992	1,401	1,000	1,160	1,573	1,878	2,023	2,378	1,097	1,219	1,275
Shareholder's Equity	-39.9%	2,153	3,580	5,765	3,161	5,205	3,630	5,772	8,187	11,093	13,272	-
Retained Earnings	-4.0%	-39,400	-37,886	-35,600	-33,900	-31,800	-29,642	-27,400	-24,804	-21,800	-19,546	-11,052
Additional Paid-In Capital	0.1%	41,520	41,466	41,408	37,041	36,960	33,272	33,159	32,990	32,878	32,817	9,874
Shares Outstanding	0%	1,466	1,466	1,466	297	297	97.00	97.00	96.00	97.00	97.00	23.00
Float	-	-	-	-	3,000	-	-	-	13,000	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)															(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Cashflow From Operations	6.1%	-1,700	-1,811	-1,834	-2,466	-2,400	-2,219	-2,800	-1,732	-2,168	-	-2,760	-1,644	-543	-665	-
Share Based Compensation	-6.9%	54.00	58.00	48.00	81.00	84.00	112	113	112	61.00	-	16.00	23.00	8.00	10.00	-
Cashflow From Investing	-	-	-	-	-24.00	-94.00	-	-5.00	-	-6.00	-	-	-	-	-	-
Cashflow From Financing	-Infinity%	-61.00	-	4,381	-44.00	4,170	-584	56.00	-	-	-	14,887	869	1,566	221	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

TIVC Income Statement

2024-03-31

Condensed Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 334	$ 376
Cost of sales	167	263
Gross profit	167	113
Operating expenses:
Research and development	256	490
Sales and marketing	505	458
General and administrative	887	1,281
Total operating expenses	1,648	2,229
Loss from operations	(1,481)	(2,116)
Net loss	$ (1,481)	$ (2,116)
Net loss per share - basic	$ (1.01)	$ (10.52)
Net loss per share - diluted	$ (1.01)	$ (10.52)
Weighted-average number of shares - basic	1,467,740	201,222
Weighted-average number of shares - diluted	1,467,740	201,222

TIVC Balance Sheet

2024-03-31

Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 1,668	$ 3,395
Accounts receivable, net	74	174
Inventory, net	774	756
Deferred offering costs	61	0
Prepaid expenses and other current assets	250	327
Total current assets	2,827	4,652
Property and equipment, net	121	122
Right-of-use assets, operating lease	304	349
Other assets	34	34
Total assets	3,286	5,157
Current liabilities
Accounts payable	547	713
Other accrued expenses	265	495
Operating lease liability, current	180	193
Total current liabilities	992	1,401
Operating lease liability	141	176
Total liabilities	1,133	1,577
Commitments and contingencies (Note 6)
Stockholders' equity
Common stock, $0.0001 par value, 200,000,000 shares authorized; 1,473,592 and 1,466,092 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	0	0
Additional paid in capital	41,520	41,466
Accumulated deficit	(39,367)	(37,886)
Total stockholders' equity	2,153	3,580
Total liabilities and stockholders' equity	$ 3,286	$ 5,157

About Tivic Health Systems, Inc.

Tivic Health Systems Inc. operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

CEO	Ms. Jennifer Ernst
WEBSITE	https://tivichealth.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	11

Tivic Health Systems, Inc. Frequently Asked Questions

What is the ticker symbol for Tivic Health Systems, Inc.? What does TIVC stand for in stocks?

TIVC is the stock ticker symbol of Tivic Health Systems, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tivic Health Systems, Inc. (TIVC)?

As of Fri May 17 2024, market cap of Tivic Health Systems, Inc. is 2.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TIVC stock?

You can check TIVC's fair value in chart for subscribers.

What is the fair value of TIVC stock?

You can check TIVC's fair value in chart for subscribers. The fair value of Tivic Health Systems, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Tivic Health Systems, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TIVC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Tivic Health Systems, Inc. a good stock to buy?

The fair value guage provides a quick view whether TIVC is over valued or under valued. Whether Tivic Health Systems, Inc. is cheap or expensive depends on the assumptions which impact Tivic Health Systems, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TIVC.

What is Tivic Health Systems, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, TIVC's PE ratio (Price to Earnings) is -0.38 and Price to Sales (PS) ratio is 2.56. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TIVC PE ratio will change depending on the future growth rate expectations of investors.